You are on page 1of 18

Kollidon® CL

Kollidon® CL-F
Kollidon® CL-SF
Kollidon® CL-M
Super-disintegrants and dissolution enhancers.
2 The Preface

New: 4 dimensions of The disintegration of a tablet can triggered by their ability to hydro-
Kollidon® CL – standard, be regarded as the initial step in philize insoluble drugs, to stabilize
fine (CL-F), superfine (CL-SF) terms of bioavailability and phar- suspensions and to form com-
and micronized (CL-M) for macological action of the active plexes, as well as by their adsorp-
your individual needs. substance. To achieve rapid disin- tive properties.
Kollidon® is well known as a tegration, a disintegrant normally
universal excipient range since has to be added to the tablet for- BASF supplies Kollidon® CL,
more than 60 years. mulation. The insoluble grades of Kollidon® CL-F and Kollidon®
Kollidon® CL, the cross- Kollidon® are widely used in the CL-SF as disintegrants for the
linked PVP, is not only one of pharmaceuticals industry for this pharmaceutical industry.
the three “super-disintegrants”. purpose. Furthermore, their use Kollidon® CL-M is usually used
Moreover, Kollidon® CL accel- as pharmaceutical excipients is as a suspension stabilizer.
erates the dissolution and the
bioavailability due to its power
to form complexes with many
insoluble actives.

Trademarks are owned


by BASF Aktiengesellschaft

Dissolution of acetylsalicylic acid tablets


100

90

80
+ 3 % Kollidon® CL
70
dissolved drug [%]

60

50

40

30

20 without Kollidon® CL

10

0
0 10 20 30 40 50 60

time [min]
The Preface 3

The theory of
disintegration of a tablet

1. Disintegrants are
very hydrophilic.

2. Spherical particles
are uniformly distributed
water in the tablet.

3. They swell during


contact with water
water or other liquids.

4. They significantly
increase volume and
disintegrate the tablet.
water

The Market Trends

Over the past few years, there ing rough surfaces after storage. Furthermore, in new drug delivery
has been a trend towards highly The disintegrants, however, still technologies such as oral dispers-
potent actives (HPAPI) and, as require the power sufficient for a ible tablets, fast disintegrants with
a consequence, a trend towards rapid disintegration. Scientific in- very good mouth feeling are in
smaller tablets. The growth rate vestigation has indicated that the strong demand. Many of these
of 19 % for HPAPIs underlines disintegration power decreases drugs go into pediatric applications
the strong market need for po- with decreasing particle size. This and to the OTC market in general,
tent disintegrants for these ap- can be confirmed by testing our where good patient compliance is
plications. These smaller tablets new materials Kollidon® CL-F and a precondition for the success of a
usually require disintegrants of Kollidon® CL-SF. Although these drug formulation. Based on these
much smaller particle size to materials have smaller particle market trends, our customers will
guarantee content uniformity and sizes, they are still potent disinte- now require new disintegrants for
to prevent the tablets from show- grants. their new applications.
4 The Products

The different Kollidon® CL grades In contrast to many other disinte-


can best be distinguished by their grants, the Kollidon® CL grades
different particle sizes: are non-water-soluble. As a conse-
quence, there is no influence on
Average particle size range [µm] the disintegration of a tablet and
the dissolution of the active due to
■ Kollidon® CL 110–130 the increased viscosity. The cros-
■ Kollidon® CL-F 20–40 povidones act as disintegrants by
■ Kollidon® CL-SF 10–30 absorbing water and subsequently
■ Kollidon® CL-M 3–10 swelling. This gain in volume is
responsible for the subsequent
All CL-grades are crosslinked, wa- disintegration of the tablet.
ter-insoluble polivinylpyrrolidones.
There are chemical but mainly However, the speed of disinte-
physical crosslinks. gration is not only based on the
swelling;

Chemical names it is a combination of many


factors such as:
■ Crospovidone
■ Crospovidonum ■ The swelling volume of the
■ Insoluble polyvinylpyrrolidone disintegrant
O ■ Crosslinked PVP ■ The swelling pressure of
N the disintegrant
■ The hydrophilic behavior of
the disintegrant
* ■ The pore sizes within the tablet
n* ■ The mechanical properties
of the tablet

Chemical crosslinks

Entangled polymer
chains (N-vinylpyrro-
lidone-polymer)

A highly (mainly
physically)
crosslinked
polymer matrix

The chemical structure of


Kollidon® CL: It is a cross-
linked homopolymer of
N-vinyl-2-pyrrolidone
6 The Application

In general, there is no perfect Comparison of the materials Even with a decreased particle
disintegrant. Disintegration is size, the new grades Kollidon®
strongly dependent on the for- The principle property of the CL-F and Kollidon® CL-SF show
mulation of the tablet in terms materials is to decrease the dis- good performance, not having
of porosity, method of manu- integration time of tablets. In the some of the drawbacks that Kolli-
facture (wet or dry granula- figure below the three Kollidon don® CL has, as explained above.
tion) and the use of different grades are compared with their
actives and other excipients. main competitive materials. Apart from the increase in tablet
Clearly, Kollidon® CL shows the disintegration, it is even more im-
strongest performance. portant that the dissolution of the
active ingredient is also increased.

Disintegration time of direct compressed tablets with different disintegrants


(6 % disintegrant in Ludipress® LCE, compressed at 18 kN)

02:09
01:55

01:40

01:26
time [min:sec]

01:12

00:57

00:43

00:28

00:14

00:00
Kollidon® Kollidon® Kollidon® Crospovi- Crospovi- Croscar- Sodium
CL CL-F CL-SF done done mellose- starch
Competitor A Competitor A sodium glycolate
(100–130 µm) (30–50 µm)
The Application 7

Dissolution of acetaminophen in deionized water


(2.7 % disintegrant in a wet granulated formulation, compressed at 18 kN)

method: paddle 100 rpm; 37 °C


100

90

80

70
drug release [%]

60 ■ Kollidon® CL
■ Kollidon® CL-F
50 ■ Kollidon® CL-SF
■ Crospovidone
40 Competitor A (100–130 µm)
■ Croscarmellose-sodium
30 ■ Crospovidone
20 Competitor A (30–50 µm)
■ Sodium starch glycolate
10

0
0 10 20 30 40 50 60 70 80 90 100 110 120

time [min]

The dissolution curves show that A requirement of many customers


Kollidon® CL has the best per- is that the tablets show a smooth
formance, followed by Kollidon® surface after storage in multidose
CL-F and Kollidon® CL-SF. In containers. Because the Kollidon®
some cases customers may wish CL grades are very hydrophilic,
to have a slightly slower disinte- they tend to absorb water and thus
gration for specific applications; produce a rough surface due to
the new materials could help to swelling. In the case of film tablets,
produce a dissolution profile fitted this might cause cracks in the film.
to such a requirement, e. g. for Tablets produced with fine materials
generics. Kollidon® CL-F and Kollidon® CL-
SF produce a very smooth surface.
8 The Application
Kollidon® CL

Kollidon® CL

Kollidon® CL is used as the stan- This is in contrast to Kollidon® CL,


dard disintegrant for all kinds of which is insoluble and which as a
fast dispersible tablet formulations. consequence does not slow down
For many years, companies have the dissolution of a oral dosage
known just how well the material form but might even increase the
performs. The main reasons for release of the active ingredient. In
using Kollidon® CL are the ad- some cases where Kollidon® CL
vantages provided compared to does not meet the requirements of
other materials like e. g. starch or the customers e. g. for wet granu-
cellulose derivatives. When used as lation with a large amount of sol-
disintegrants, these products tend vent, Kollidon® CL-F or Kollidon®
to form highly viscous systems CL-SF are suitable replacements.
when in contact with water.

.......... .......... ..........


300 µm 50 µm 10 µm

Kollidon® CL
The Application 9

Kollidon® CL-F

Kollidon® CL-F

Kollidon® CL-F is the perfect Capsules filled with microtablets (capsule size 00–4)
alternative when formulators are
looking for a disintegrant with 8.5 mm
strong disintegration power in 5.2 mm
combination with a smooth tablet
surface. With Kollidon® CL,
however, some problems might
23.5 mm

14.1 mm
occur when the tablet is very
hygroscopic and packed in a
multi-dose container.

.......... .......... ..........


300 µm 50 µm 10 µm

Kollidon® CL-F

Kollidon® CL-F should be used for step where large amounts of


the development of small tablets solvent are needed e. g. for
when fine particles are required to dissolving the active.
avoid content uniformity prob-
lems. Furthermore, the material However, in some cases,
is able to absorb large amounts Kollidon® CL-SF might be the
of solvent. This can be beneficial best solution for a specific
when customers use such large application.
amounts during a wet granulation

Microtablets,
2 mm diameter
10 The Application
Kollidon® CL-SF

Kollidon® CL-SF

Kollidon® CL-SF has advantages CL-SF might be used as a regular


when it comes to special appli- disintegrant when customers have
cations, for example oral fast dis- a wet granulation process that
persible tablets. The main reason uses large amounts of solvent.
is reliable disintegration power in Kollidon® CL-SF has the highest
combination with a very smooth solvent (water/ethanol etc.) uptake
cream-like mouth feel. Neverthe- capacity of all the crospovidones
less, in some cases, Kollidon® produced by BASF.

..........
300 µm Kollidon® CL-SF

.......... ..........
50 µm 10 µm
12 The Examples

Formulation of Nifedipine tablets (granulated)

Nifedipine 10 mg (5.85 %)
Kollidon® VA 64 10 mg (5.85 %)
Ludipress® LCE 100 mg (58.50 %)
Kollidon® CL-F or -SF 50 mg (29.22 %)
Magnesium stearate 1 mg (0.58 %)

Tablet weight 171 mg (100 %)

Formulation of Haloperidol tablets (direct tabletting)

Haloperidol 2 mg (2.5 %)
Ludipress® LCE 75 mg (93.75 %)
Kollidon® CL 2.5 mg (3.12 %)
Magnesium stearate 0.5 mg (0.63 %)

Tablet weight 80 mg (100 %)


The Overview 13

As far as disintegrants are con- ensure disintegration. One particu- In the figure, the disintegration
cerned, there are many products lar disadvantage of disintegrants test results of tablets produced
in the market starting with the based on starch and of the cellu- with granulated material are
basic starches derived from maize, lose derivatives is the increase of shown. These clearly show the
rice, corn and potato. They have viscosity after disintegration. The strengths of the crospovidones,
been used for a long time but have first question is always related to especially the Kollidon® CL
certain disadvantages in terms of the real effect of the disintegrant grades.
the amount that is needed to on the disintegration time.

Disintegration of tablets made of granules (2,7 % disintegrant extragranular use,


compressed at 18 kN)

35
33:56
30
disintegration time [min]

25
22:37 23:28
20

15
12:46 12:30
10 11:08
08:55 09:06

0
Kollidon® Kollidon® Kollidon® Kollidon® Crospovi- Crospovi- Croscar- Sodium
CL CL-F CL-SF CL-M done done mellose- starch
Competitor A Competitor A sodium glycolate
(100–130 µm) (30–50 µm)
14 The Overview

Disintegrants on the market

Required Disinte- Hardness Issues during


% gration power of the tablets storage at
1: low high humidity
10: high

Starches 3–15 3 Low *

Starch derivatives

Sodium starch glycolate 2–8 4 High Brown spots

Cellulose derivatives

Carmellose-sodium 1–6 5 Medium *

Croscarmellose-sodium 0.5–5 7 High Brown spots


(most cases 2–3)

Carmellose-calcium 5–15 5 Medium *

HPC 5–25 5 High *

Crospovidone grades

Compet. A (100–130 µm) 2–5 8 High Rough surface

Compet. A (30–50 µm) 2–5 7 High Smooth surface

Kollidon® CL 2–5 9 Medium Rough surface

Kollidon® CL-F 2–5 8 High Smooth surface

Kollidon® CL-SF 2–5 7 Very high Smooth surface

*: Not tested
The Summary 15

The following table describes ceutical industry and their


the advantages of each material customers, the patients.
for our customers – the pharma-

Benefits for manufacturers Benefits for patients Main applications

Kollidon® CL The super-disintegrant, Fast drug absorption Disintegrant for


very fast disintegration for most APIs standard tablets

Kollidon® CL-F No content uniformity Easy to swallow Small tablets,


problems especially in due to tablet size tablets stored under
small tablets high humidity

Kollidon® CL-SF Perfect for fast Best mouthfeel Fast dispersible


dispersible tablets, tablets,
excellent tablet surface intragranular
disintegrant for
wet granulation

Kollidon® CL-M Stable dispersions Easy to redisperse Suspensions

Depending on the preferred disintegration and dissolution rate, our customers


can select the excipient of choice from our comprehensive product range.
Please write Please
Title/Name
apply
in block letters.
postage
Thank you. Department stamp.

Company

Address

Town Reply card

Country BASF
Aktiengesellschaft
Telephone G-MEP/ME – Li 554
Attn: Dr. Hubertus Folttmann
Fax Carl-Bosch-Straße 64
D-67117 Limburgerhof
e-Mail Germany

Fax Reply

Local contact:

or Headquarter Germany:

+49-621-60-2 86 40

Please complete, copy and fax to us,


or detach the postcard and send it to us.

Please send the ■ Technical information


following information: on Kollidon® VA 64.

■ Technical information on ■ Technical information


Kollidon® CL grades. on Kollidon® VA 64 Fine.

■ Sample of ■ Technical information on


Kollidon® CL, 0.5 kg. Ludipress®.
■ Sample of
Kollidon® CL-F, 0.5 kg. ■ DVD “Pharmaceutical Excipients
■ Sample of by BASF Fine Chemicals”.
Kollidon® CL-SF, 0.2 kg.
■ Sample of ■ Newsletter “ExAct”
Kollidon® CL-M, 0.5 kg. (Excipients & Actives for Pharma).

■ Please contact me, I would


like to know more about
Kollidon® CL.
Please send the ■ Technical information
following information: on Kollidon® VA 64.

■ Technical information on ■ Technical information


Kollidon® CL grades. on Kollidon® VA 64 Fine.

■ Sample of ■ Technical information on


Kollidon® CL, 0.5 kg. Ludipress®.
■ Sample of
Kollidon® CL-F, 0.5 kg. ■ DVD “Pharmaceutical Excipients
■ Sample of by BASF Fine Chemicals”.
Kollidon® CL-SF, 0.2 kg.
■ Sample of ■ Newsletter “ExAct”
Kollidon® CL-M, 0.5 kg. (Excipients & Actives for Pharma).

■ Please contact me, I would


like to know more about
Kollidon® CL.

We look forward to answering any questions you may have. Please


fill in the postcard, detach it and return it to the address overleaf.

Please contact your local BASF company or


one of the following regional centers:

Asia Europe North America South America


BASF Asia Pacific BASF Aktiengesellschaft BASF Corporation BASF S.A.
Regional HQ MEE/HP – J 550 Pharma Solutions Human Fine Chemicals
Pharma Solutions Mr. Peter Hoffmann Mr. Javier Beeck Ms. Vanessa Occhipinti
Dr. Danilo Mercado D-67056 Ludwigshafen 100 Campus Drive Estrada Samuel
BASF East Asia Regional Germany Florham Park, NJ 07932 Aizemberg, 1707
Headquarters Ltd. Phone: +49-621-60-7 69 28 USA 09851-550 São Bernardo
45th Floor, Jardine House, Fax: +49-621-60-7 69 40 Phone: +1-973-245-6381 do Campo – SP
No.1 Connaught Place, peter.01.hoffmann@ Fax: +1-973-245-6763 Brazil
Central, Hong Kong basf.com javier.beeck@ Phone: +55-11-4343-3341
Phone: +852-27311-588 basf.com Fax: +55-11-4343-2255
Fax.: +852-27349-638 vanessa.occhipinti@
mercadd@ basf.com
basf-east-asia.com.hk

www.pharma-solutions.basf.com
■ Excipients ■ Actives
Kollidon® grades Cremophor ® Ephedrines
Group of povidone grades and Pseudoephedrines
and copovidone Solutol® HS 15 Theophylline
products suitable Range of different Caffeine
mainly as tablet ethoxylated Isotretinoin
binders, emulsifiers and Tretinoin
crospovidone as solubilizers Ibuprofen
tablet disintegrant suitable for topical, Dobutamine
and dissolution oral and parenteral Dopamine
enhancer. formulations. Isometheptene mucate
Kollidon® SR Soluphor ® P Oxymetazoline
Matrix sustained 2-pyrrolidone. PVP-Iodine
release polymer. Lutrol® grades Selegiline
Ludipress® grades Range of PEGs Xylometazoline
Direct tabletting (Lutrol® E range)
aids for faster and poloxamers APIs by Orgamol
product develop- (Lutrol® F range)
ment and speedier for a wide variety Vitamins
processing. of pharmaceutical
Kollicoat ® grades dosage forms. ■ Contract
Range of aqueous Manufacturing
based film formers,
cost efficient and ■ Value Added
ecological.

Pharma Solutions by BASF

BASF offers more than BASF Aktiengesellschaft


cGMP quality and supply Fine Chemicals Division
safety: technical expertise. Pharma Solutions
Our technical service is 67056 Ludwigshafen
always at your side. Germany

BASF wishes to create ■ Fax +49-621-60-2 86 40


a prosperous and sustain- ■ pharma.solutions@basf.com
able future with you as our ■ www.pharma-solutions.basf.com
customer – and partner.

BASF – the world’s leading chemical company – can look


back on well over 140 years of success and has attained an
outstanding position as a reliable partner.

Our portfolio for the pharmaceutical industry comprises a


comprehensive range of major and new active ingredients
and excipient brands.
MEMP 060401e-00

You might also like